SARS-CoV-2-Impfung: Auch bei "besonderen" PatientenVaccination against COVID-19: general recommendations and special populations

被引：0
作者：
Ulrich Seybold
机构：
[1] Klinikum Innenstadt der LMU München,Medizinische Klinik u. Poliklinik IV / Sektion Klinische Infektiologie
来源：
MMW - Fortschritte der Medizin | 2022年 / 164卷 / 8期
关键词：
Vaccination; SARS-CoV-2; COVID-19; mRNA; Booster;
D O I：
10.1007/s15006-022-0924-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：42 / 51
页数：9
相关论文
共 50 条
  • [21] Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
    Satarker S.
    Ahuja T.
    Banerjee M.
    E V.B.
    Dogra S.
    Agarwal T.
    Nampoothiri M.
    Current Pharmacology Reports, 2020, 6 (5) : 203 - 211
  • [22] COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
    Stojan Peric
    Milos Rankovic
    Ivo Bozovic
    Vanja Radosavljevic
    Ivan Marjanovic
    Ivana Basta
    Dragana Lavrnic
    Acta Neurologica Belgica, 2023, 123 : 529 - 536
  • [23] Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
    Sharun, Khan
    Dhama, Kuldeep
    Patel, Shailesh Kumar
    Pathak, Mamta
    Tiwari, Ruchi
    Singh, Bhoj Raj
    Sah, Ranjit
    Bonilla-Aldana, D. Katterine
    Rodriguez-Morales, Alfonso J.
    Leblebicioglu, Hakan
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2020, 19 (01)
  • [24] An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Pascual-Iglesias, Alejandro
    Canton, Javier
    Ortega-Prieto, Ana Maria
    Jimenez-Guardeno, Jose M.
    Regla-Nava, Jose Angel
    PATHOGENS, 2021, 10 (08):
  • [25] Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
    Cheng, Haoyue
    Peng, Zhicheng
    Si, Shuting
    Alifu, Xialidan
    Zhou, Haibo
    Chi, Peihan
    Zhuang, Yan
    Mo, Minjia
    Yu, Yunxian
    VACCINES, 2022, 10 (07)
  • [26] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (07) : 392 - 400
  • [27] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [28] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (06) : 392 - 400
  • [29] Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
    Khan Sharun
    Kuldeep Dhama
    Shailesh Kumar Patel
    Mamta Pathak
    Ruchi Tiwari
    Bhoj Raj Singh
    Ranjit Sah
    D. Katterine Bonilla-Aldana
    Alfonso J. Rodriguez-Morales
    Hakan Leblebicioglu
    Annals of Clinical Microbiology and Antimicrobials, 19
  • [30] Preventive Medicinal Plants and their Phytoconstituents against SARS-CoV-2/COVID-19
    Nema, Neelesh Kumar
    Mamdapur, Ghouse Modin Nabeesab
    Sarojam, Smitha
    Khamborkar, Swapnil Devidas
    Sajan, Linson Cheruveettil
    Sabu, Sachithra
    Chacko, Baby Kumaranthara
    Jacob, Viju
    PHARMACOGNOSY RESEARCH, 2021, 13 (04): : 173 - 191
12345